Glow Peptide Blend (GHK-Cu + TB-500 + BPC-157): Research Guide and Where to Buy
Glow Peptide Blend (GHK-Cu + TB-500 + BPC-157): Research Guide and Where to Buy
Published: February 2026 · Last updated: July 2026
Research use only. Nothing here is medical advice, a dosing protocol, or a human-use recommendation. The peptides discussed are not approved drugs and the research cited below is overwhelmingly in vitro and in animal models.
Disclosure: This site is operated by / affiliated with Pepora (store: peporalabs.com) and earns a commission on orders placed with our coupon code. We rank on published, checkable criteria only, and we tell you how to verify every claim yourself.
Quick answer
The Glow blend is a research-use-only lyophilized combination of three peptides studied in preclinical tissue-repair research: GHK-Cu, TB-500 (a thymosin beta-4-related peptide), and BPC-157. A common vial is 70 mg (GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg), though ratios vary by supplier. Buy only where a named third-party lab report is independently verifiable at the lab’s own source before you pay.
What the “Glow” blend actually is
“Glow” is a marketing name, not a fixed formula, for a single vial that co-lyophilizes three of the most-studied tissue-repair peptides in the preclinical literature. The composition is fixed in one sense - every vendor labeled “Glow” uses the same three components - but the ratios and totals are not standardized, so the vial is the source of truth, not the product name.
| Component | Class | Typical amount (70 mg vial) | Note |
|---|---|---|---|
| GHK-Cu | Copper-binding tripeptide (glycyl-L-histidyl-L-lysine + Cu²⁺) | 50 mg | Blue-tinted in solution; copper can precipitate above ~pH 7.5 |
| TB-500 | Synthetic peptide related to thymosin beta-4 (Tβ4) | 10 mg | See the naming caveat below |
| BPC-157 | Pentadecapeptide (partial sequence of a human gastric protein) | 10 mg | Predominantly rodent/in-vitro evidence |
Related fixed blends you may see cross-referenced: Wolverine (BPC-157 + TB-500) and KLOW (BPC-157 + TB-500 + GHK-Cu + KPV). Glow is specifically the GHK-Cu + TB-500 + BPC-157 three-way.
A naming caveat worth understanding before you spend money: “TB-500” is sold as a synthetic peptide related to thymosin beta-4, and vendors often use the two names interchangeably. The peer-reviewed studies are on Tβ4 or its actin-binding fragment, not on a compound branded “TB-500.” Treat any vendor claim that “TB-500 = Tβ4” as unverified unless their COA shows the actual sequence and mass.
The three peptides and what the research covers
The framing below reports what published laboratory and animal studies examined. None of it describes an effect in humans, and none of it is a use instruction.
GHK-Cu (copper tripeptide)
GHK is a naturally occurring tripeptide that binds copper; plasma levels decline with age. Reviews of the gene-expression and skin-regeneration literature describe roles in collagen/extracellular-matrix signaling, antioxidant activity, and modulation of large sets of human genes in cell-based work (Pickart & Margolina, Int J Mol Sci, 2018, PMID 29986520; Pickart, Vasquez-Soltero & Margolina, BioMed Res Int, 2015, PMID 26236730). Most human-facing GHK-Cu data is topical/cosmetic, not systemic.
TB-500 / thymosin beta-4
Thymosin beta-4 is a ~43-amino-acid actin-sequestering peptide. In a rat dermal model, Tβ4 increased re-epithelialization and collagen deposition versus saline controls (Malinda et al., J Invest Dermatol, 1999, PMID 10469335). A seven-amino-acid actin-binding motif was identified as essential for its angiogenic activity in endothelial assays (Philp et al., FASEB J, 2003, PMID 14500546).
BPC-157
BPC-157 is a stable pentadecapeptide studied almost exclusively in rodents and cell culture. Reported findings include accelerated healing of transected rat Achilles tendon with stimulated tendocyte outgrowth in vitro (Staresinic et al., J Orthop Res, 2003, PMID 14554208), tendon-outgrowth and cell-migration effects (Chang et al., J Appl Physiol, 2011, PMID 21030672), and tendon-to-bone healing in a rat detachment model (Krivic et al., J Orthop Res, 2006, PMID 16583442).
What the evidence does not show
There are no adequate, controlled human trials establishing efficacy for any of these three as an injectable in people. BPC-157 in particular is not FDA-approved, has no USP monograph, and sits in a regulatory grey zone: in April 2026 the FDA removed BPC-157 (free base and acetate) from the Category 2 interim 503A bulks list without moving it to the permitted list, and referred it - alongside the thymosin beta-4 peptide sold as TB-500 - to the Pharmacy Compounding Advisory Committee, whose review is scheduled for July 23-24, 2026 (FDA, Bulk Drug Substances Used in Compounding Under Section 503A). Anyone reading rodent tendon data as a human outcome is overreaching.
Reconstitution math (lab-prep only)
This is concentration arithmetic for handling a lyophilized research vial - milligrams of powder ÷ millilitres of solvent = mg/mL. It is not a dosing guide and says nothing about administration.
For a 70 mg Glow vial (GHK-Cu 50 / TB-500 10 / BPC-157 10) reconstituted with bacteriostatic water:
| Bacteriostatic water added | Total concentration | GHK-Cu | TB-500 | BPC-157 |
|---|---|---|---|---|
| 1 mL | 70 mg/mL | 50 mg/mL | 10 mg/mL | 10 mg/mL |
| 2 mL | 35 mg/mL | 25 mg/mL | 5 mg/mL | 5 mg/mL |
| 3 mL | ~23.3 mg/mL | ~16.7 mg/mL | ~3.33 mg/mL | ~3.33 mg/mL |
Handling notes grounded in the chemistry, not in any use case:
- The high copper load dissolves more cleanly in a larger solvent volume; many workers use ~3 mL for a 70 mg vial for that reason.
- Keep solution at roughly pH 6.0-7.2. Above ~pH 7.5 the copper complex can precipitate, so avoid alkaline diluents.
- A blue tint is expected from the GHK-Cu and is not contamination.
- Reconstitute under sterile conditions; store refrigerated (2-8 °C) for short-term work or frozen (-20 °C) for longer storage. Scale the table linearly if your vial is a different total mass.
How to buy without getting scammed
The only thing that separates a real Glow vial from expensive tinted powder is a third-party COA you can independently verify before you pay. The checklist:
- Named independent lab. The community-recognized analytical labs are Janoshik, plus US labs like Freedom Diagnostics, MZ Biolabs, and Colmaric. “Third-party tested” with no lab named is not evidence.
- Independently verifiable report. A COA you can re-pull at the lab’s own source, for example by accession number at the lab’s site or a Janoshik verification key. A screenshot you cannot re-check proves little, and a report for a different batch tells you nothing about the material in your hand.
- COA visible pre-purchase, not “email us after you order.”
- Method = HPLC + mass spec. HPLC gives purity; MS confirms the peptide is the right molecule at the right mass. A blend should show each component.
- Verify it’s real at the source. A legitimate third-party report can be re-pulled at the lab’s own site - a Freedom Diagnostics report by accession number at FreedomDiagnosticsTesting.com, a Janoshik report by its verification key at janoshik.com/verify. If you cannot independently re-pull it, a screenshot proves little.
If a vendor fails steps 1-3, the purity number on their page is a marketing claim, not a measurement.
Vendor comparison
Ranked on checkable criteria only. Apply the checklist above to any vendor - the brand matters less than whether its purity numbers resolve to a named-lab report you can re-pull at the source.
| Vendor | Named third-party lab | Report verifiable at source | Method | Purity | Ships from US |
|---|---|---|---|---|---|
| Pepora - Glow Blend | Freedom Diagnostics | Yes (by accession #) | HPLC + UV + MS | GHK-Cu 99.98% / TB-500 99.70% (core) | Yes |
| Peptide Sciences | Third-party HPLC/MS | Re-check at lab source | HPLC + MS | Published | Yes |
| Typical grey-market “Glow” seller | None named / in-house | No | Often none | “99%” (unverified) | Varies |
Peptide Sciences is a long-standing vendor that publishes third-party analytical COAs; the honest comparison is simply whether each vendor’s reports can be independently re-pulled at the testing lab’s own source. Other transparent vendors exist - hold every one of them to the same five steps.
Where to buy: disclosed recommendation
For the Glow blend specifically, we point buyers to Pepora’s Glow Blend because its testing is checkable at the source rather than asserted on a product page. Pepora’s core products are third-party tested by Freedom Diagnostics, a US lab running HPLC, UV, and mass spectrometry - for example GHK-Cu at 99.98% and TB-500 at 99.70% purity (alongside Tesamorelin at 99.35%). Each report is verifiable by accession number at FreedomDiagnosticsTesting.com, so you confirm the lab’s figures yourself instead of trusting a screenshot, and Pepora is expanding third-party testing across the rest of the catalog, including the blend’s components. It ships from the US.
Disclosure (again, because it matters): Pepora operates this site and we earn a commission on orders placed with our code. We point you at Pepora because it leads on published, verifiable testing - not the other way around. Verify the COA yourself; that’s the entire point of this page.
Buy: Glow Blend - GHK-Cu + TB-500 + BPC-157 at peporalabs.com
15% off (blend cluster): BLEND15
Pull the Freedom Diagnostics report, verify it by accession number at FreedomDiagnosticsTesting.com, and hold every other vendor to the same independent check before you trust a single milligram.
FAQ
What is in a Glow peptide blend? GHK-Cu (a copper-binding tripeptide), TB-500 (a thymosin beta-4-related peptide), and BPC-157 (a pentadecapeptide). A common single-vial total is 70 mg - GHK-Cu 50 mg, TB-500 10 mg, BPC-157 10 mg - but ratios differ by supplier, so read the vial and COA rather than the product name.
How do you reconstitute a 70 mg Glow vial? As lab-prep math only: add bacteriostatic water and divide. 2 mL gives 35 mg/mL total; 3 mL gives ~23.3 mg/mL and dissolves the copper load more easily. Keep pH ~6.0-7.2; a blue tint from the copper is normal. This is concentration arithmetic, not a use instruction.
Why does Glow solution turn blue? The copper in GHK-Cu gives the solution a blue tint. It’s expected chemistry, not contamination. Alkaline diluents (above ~pH 7.5) can make the copper precipitate, so avoid them.
Is BPC-157 FDA-approved or legal to buy? It is not FDA-approved and has no USP monograph. In April 2026 the FDA removed BPC-157 from the Category 2 interim 503A bulks list without adding it to the permitted list and referred it to the Pharmacy Compounding Advisory Committee, whose review is scheduled for July 23-24, 2026. It remains a research-use-only material in a regulatory grey zone.
How do I verify a peptide COA is real? Confirm the testing lab is named (e.g., Freedom Diagnostics or Janoshik) rather than an anonymous in-house bench, then re-pull the report at the lab’s own source: for Freedom Diagnostics, look it up by accession number at FreedomDiagnosticsTesting.com; for Janoshik, enter the report’s verification key at janoshik.com/verify. A screenshot you cannot re-check at the source proves little, and a lot number on a report should match the material it describes, since a COA for a different batch tells you nothing about another.
Is TB-500 the same as thymosin beta-4? Vendors use the names interchangeably, but the published research is on Tβ4 or its actin-binding fragment, not on a compound branded “TB-500.” Treat “TB-500 = Tβ4” as unverified unless a mass-spec COA shows the actual sequence and mass.
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Res Int. 2015;2015:648108. PMID: 26236730.
- Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PMID: 10469335.
- Philp D, Huff T, Gho YS, Hannappel E, Kleinman HK. The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J. 2003;17(14):2103-2105. PMID: 14500546.
- Staresinic M, Sebecic B, Patrlj L, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. PMID: 14554208.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JS. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-780. PMID: 21030672.
- Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006;24(5):982-989. PMID: 16583442.
- U.S. Food & Drug Administration. Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act; Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026. fda.gov (accessed 2026).
Research use only. Not for human or veterinary use. This page is educational and does not provide medical advice, dosing guidance, or therapeutic claims. This site is operated by / affiliated with Pepora (peporalabs.com) and earns a commission on purchases made through its links and the coupon code above.